0

CILOXAN از شرکت NOVARTIS

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CILOXAN از شرکت NOVARTIS

New Drug Application (NDA): 020369

Company: NOVARTIS

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CILOXAN CIPROFLOXACIN HYDROCHLORIDE EQ 0.3% BASE OINTMENT;OPHTHALMIC Prescription

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/30/1998 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20369lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20369ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020369_ciloxan.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/17/2017 SUPPL-22 Labeling-Container/Carton Labels, Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020369s022lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020369Orig1s022ltr.pdf

08/05/2016 SUPPL-21 Manufacturing (CMC)

Label is not available on this site.

09/09/2015 SUPPL-20 Manufacturing (CMC)

Label is not available on this site.

07/15/2004 SUPPL-10 Manufacturing (CMC)-Packaging

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20369s009,010lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20369s009,010ltr.pdf

07/15/2004 SUPPL-9 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20369s009,010lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20369s009,010ltr.pdf

08/19/2003 SUPPL-7 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020369s006s007lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20369scm006,slr007ltr.pdf

08/19/2003 SUPPL-6 Manufacturing (CMC)

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020369s006s007lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20369scm006,slr007ltr.pdf

12/11/2000 SUPPL-5 Manufacturing (CMC)

Label is not available on this site.

07/07/2000 SUPPL-4 Labeling

Label is not available on this site.

09/28/1999 SUPPL-3 Manufacturing (CMC)-Packaging

Label is not available on this site.

04/07/1999 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

02/05/1999 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
02/17/2017 SUPPL-22

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020369s022lbl.pdf
02/17/2017 SUPPL-22

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020369s022lbl.pdf
07/15/2004 SUPPL-10

Manufacturing (CMC)-Packaging

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20369s009,010lbl.pdf
07/15/2004 SUPPL-9

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20369s009,010lbl.pdf
08/19/2003 SUPPL-7

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020369s006s007lbl.pdf
08/19/2003 SUPPL-6

Manufacturing (CMC)

Label (PDF)

This supplement type does not usually require new labeling.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020369s006s007lbl.pdf
03/30/1998 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20369lbl.pdf
بخوانید  CILOXAN از شرکت NOVARTIS
برچسب‌ها:

نظرات کاربران